MedPath

Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide Prior to Hysterosalpingography

Not Applicable
Completed
Conditions
Infertility, Female
Interventions
Registration Number
NCT04500470
Lead Sponsor
Aswan University Hospital
Brief Summary

The aim of our study is to determine the efficacy of Ketoprofen with or without vaginal isonicotinic acid hydrazide on the pain scores during HSG.

Detailed Description

hysterosalpingography can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring uterine depth, inserting the cannula; and injection of the dye

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • any patient came for Hysterosalpingography
Exclusion Criteria
  • any patient has contraindication to HSG

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group AKetoprofen + INHpatients will have of oral Ketoprofen 60 minutes before the procedure plus 3 table 900 mg vaginal isonicotinic acid hydrazide by the patient 12 hours before the procedure
Group BKetoprofen + placebopatients will have of oral Ketoprofen 60 minutes before the procedure plus 3 table vaginal placebo by the patient 12 hours before the procedure
Primary Outcome Measures
NameTimeMethod
Intensity of pain15 minutes

pain during the procedure assessed by the visual analog scale from 0=no pain to 10 = the worst pain imaginable

Secondary Outcome Measures
NameTimeMethod
Intensity of pain30 minutes after the procedure

Pain intensity will be assessed by visual analogue scale 30 minutes after the procedure.visual analogue scale ranging from 0 to 10

Trial Locations

Locations (1)

Aswan University Hospital

🇪🇬

Aswan, Egypt

© Copyright 2025. All Rights Reserved by MedPath